Caplyta (lumateperone) treatment is not associated with the weight gain that some other antipsychotic drugs are. Caplyta is an atypical antipsychotic that is used to treat schizophrenia and bipolar depression in adults. Continue reading
Weight gain was not common. At 6 months, the average weight change for people on CAPLYTA was -0.02 lbs. Movement disorders were not common.
In clinical trials, weight gain occurred in people taking Caplyta. This side effect was not common. If you gain weight while taking Caplyta, talk with your doctor. Weight gain may be a symptom of a more serious side effect, such as diabetes or increased cholesterol and triglyceride levels.
Caplyta's exceptional tolerability sets it apart from other antipsychotics, with a low incidence of weight gain, metabolic abnormalities, and
If you gain weight while taking Caplyta, talk with your doctor. Weight gain may be a symptom of a more serious side effect, such as diabetes or increased cholesterol and triglyceride levels.
Weight gain is a possible side effect of antipsychotic drugs such as Caplyta. You may gain a small amount of weight whether you take Caplyta
Caplyta (lumateperone) treatment is not associated with the weight gain that some other antipsychotic drugs are. Caplyta is an atypical
fat (cholesterol and triglyceride) levels in your blood and weight gain. fat levels and weight before you start and during your treatment with CAPLYTA.
At 6 months, the average weight change for people on CAPLYTA was -0.02 lbs. CAPLYTA may cause weight gain. You and your healthcare provider should monitor your
Comments